Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 7569315)

Published in Res Microbiol on November 02, 1995

Authors

S M Newton1, T M Joys, S A Anderson, R C Kennedy, M E Hovi, B A Stocker

Author Affiliations

1: Department of Microbiology and Immunology, Stanford University School of Medicine, CA 94305-5402.

Articles citing this

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73

Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun (1998) 1.72

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun (2006) 1.63

Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun (2004) 1.49

Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system. J Bacteriol (2002) 1.10

Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. Infect Immun (1999) 1.05

Sequestration of zinc oxide by fimbrial designer chelators. Appl Environ Microbiol (2000) 1.04

Motor rotation is essential for the formation of the periplasmic flagellar ribbon, cellular morphology, and Borrelia burgdorferi persistence within Ixodes scapularis tick and murine hosts. Infect Immun (2015) 0.91

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Infect Immun (2004) 0.89

Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains. Infect Immun (2003) 0.86

Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins. Braz J Microbiol (2008) 0.83

Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization. Cell Mol Immunol (2011) 0.79

Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant. PLoS One (2016) 0.77

Articles by these authors

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90

Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping. J Gen Microbiol (1972) 8.09

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03

Covalent structure of three phase-1 flagellar filament proteins of Salmonella. J Mol Biol (1985) 4.69

Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56

Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32

The covalent structure of the phase-1 flagellar filament protein of Salmonella typhimurium and its comparison with other flagellins. J Biol Chem (1985) 4.11

Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer. Mol Microbiol (1988) 3.59

Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42

Complementation of non-flagellate Salmonella mutants. J Gen Microbiol (1965) 3.36

Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34

Origin and molecular specification of striatal interneurons. J Neurosci (2000) 3.24

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21

Salmonella typhimurium mutants generally defective in chemotaxis. J Bacteriol (1976) 3.10

Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03

Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science (1989) 2.83

A new fla gene in Salmonella typhimurium--flaR--and its mutant phenotype-superhooks. Arch Mikrobiol (1973) 2.80

Transduction by bacteriophage P22 in nonsmooth mutants of Salmonella typhimurium. J Bacteriol (1967) 2.78

Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb Pathog (1987) 2.66

Nonsense motility mutants in Salmonella typhimurium. Genetics (1973) 2.66

Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am J Vet Res (1984) 2.60

Transduction by phage P1kc in Salmonella typhimurium. Virology (1974) 2.52

Relation of lipopolysaccharide character to P1 sensitivity in Salmonella typhimurium. Virology (1974) 2.43

Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J (1989) 2.38

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05

Construction of delta aroA his delta pur strains of Salmonella typhi. J Bacteriol (1988) 2.03

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01

Correlation between susceptibility to bacteriophage PBS1 and motility in Bacillus subtilis. J Bacteriol (1965) 1.96

Unique sequences in region VI of the flagellin gene of Salmonella typhi. Mol Microbiol (1989) 1.90

ES18, a general transducing phage for smooth and nonsmooth Salmonella typhimurium. Virology (1970) 1.88

Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88

Phase variation of flagellar antigens in Salmonella: abortive transduction studies. J Gen Microbiol (1967) 1.87

Ultraviolet light protection, enhancement of ultraviolet light mutagenesis, and mutator effect of plasmid R46 in Salmonella typhimurium. J Bacteriol (1976) 1.85

Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect Immun (1985) 1.83

Salmonella typhimurium mutants defective in UDP-D-galactose:lipopolysaccharide alpha 1,6-D-galactosyltransferase. Structural, immunochemical, and enzymologic studies of rfaB mutants. J Biol Chem (1983) 1.82

Variation in composition of chromosome fragments transduced by phage P22. Virology (1965) 1.81

An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J Infect Dis (1987) 1.81

R (transmissible drug-resistance) factors in Salmonella typhimurium: pattern of transduction by phage P22 and ultraviolet-protection effect. J Gen Microbiol (1968) 1.81

Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice. Infect Immun (1988) 1.81

Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun (1983) 1.81

Mapping of rfa Genes in Salmonella typhimurium by ES18 and P22 Transduction and by Conjugation. J Bacteriol (1972) 1.80

Segregation of the mutator property of plasmid R46 from its ultraviolet-protecting property. Mol Gen Genet (1979) 1.79

Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77

Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77

Genetics and cultural properties of mutants of Salmonella typhimurium lacking glucosyl or galactosyl lipopolysaccharide transferases. Nature (1968) 1.73

Molecular analyses of the Salmonella g. . . flagellar antigen complex. J Bacteriol (1993) 1.70

DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiation. J Comp Neurol (1999) 1.68

Integration, at hag or elsewhere, of H2 (phase-2 flagellin) genes transduced from Salmonella to Escherichia coli. Genetics (1975) 1.66

A Salmonella typhimurium virulence gene linked to flg. Infect Immun (1989) 1.64

Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev Biol Stand (1983) 1.64

Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64

Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60

Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol (1992) 1.57

Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am J Vet Res (1984) 1.54

Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy (2004) 1.52

Genetics of sensitivity of Salmonella species to colicin M and bacteriophages T5, T1, and ES18. J Bacteriol (1977) 1.52

Mutation of flgM attenuates virulence of Salmonella typhimurium, and mutation of fliA represses the attenuated phenotype. J Bacteriol (1994) 1.51

A key role for type 1 pili in enterobacterial communicability. Mol Microbiol (1992) 1.51

Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49

A new class of heptose-defective mutant of Salmonella typhimurium. Eur J Biochem (1973) 1.48

Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48

Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice. J Immunol (1984) 1.48

Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46

Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect Immun (1989) 1.43

The nucleotide sequence of the H-1r gene of Salmonella rubislaw. Nucleic Acids Res (1986) 1.43

Mono- and bi-phasic Salmonella typhi: genetic homogeneity and distinguishing characteristics. Mol Microbiol (1992) 1.43

Identification of an antibody binding site in the phase-1 flagellar protein of Salmonella typhimurium. Microbios (1976) 1.41

The primary structure of the phase-1 flagellar protein of Salmonella typhimurium. I. The tryptic peptides. J Biol Chem (1972) 1.40

Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38

Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei. J Clin Microbiol (1995) 1.38

Adsorption Specificity of Bacteriophage PBS1. J Bacteriol (1966) 1.38

Gene rfaH, which affects lipopolysaccharide core structure in Salmonella typhimurium, is required also for expression of F-factor functions. J Bacteriol (1981) 1.38

Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine (1988) 1.38

Immunity conferred by Aro- Salmonella live vaccines. Microb Pathog (1991) 1.38

Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38

Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36

Novel role of phosphorylation in Fe-S cluster stability revealed by phosphomimetic mutations at Ser-138 of iron regulatory protein 1. Proc Natl Acad Sci U S A (1998) 1.36

Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36

Genes aroA and serC of Salmonella typhimurium constitute an operon. J Bacteriol (1985) 1.35

Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect Immun (1987) 1.35

Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35

Some galE mutants of Salmonella choleraesuis retain virulence. Infect Immun (1986) 1.34

Iron-responsive element-binding protein. Phosphorylation by protein kinase C. J Biol Chem (1993) 1.34

Genetic determination of bacterial virulence, with special reference to Salmonella. Curr Top Microbiol Immunol (1986) 1.34

The structure of flagella and the genetic control of flagellation in Eubacteriales. A review. Antonie Van Leeuwenhoek (1968) 1.32

Salmonella typhimurium mutants of RfaH-phenotype: genetics and antibiotic sensitivities. J Gen Microbiol (1980) 1.32

Isolation and serological analysis of mutant forms of flagellar antigen i of Salmonella typhimurium. J Gen Microbiol (1966) 1.32

Comparison of the virulence of O:9,12 and O:4,5,12 Salmonella typhimurium his+ transductants for mice. Infect Immun (1977) 1.30

Molecular analyses of the phase-2 antigen complex 1,2,.. of Salmonella spp. J Bacteriol (1995) 1.30

Suppression of proline requirement of proA and proAB deletion mutants in Salmonella typhimurium by mutation to arginine requirement. J Bacteriol (1969) 1.30

Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29

Suppression of amber and ochre mutants in Salmonella typhimurium by a mutant F'-1-gal factor carrying an ochre suppressor gene. J Bacteriol (1969) 1.26

Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine (1996) 1.25

Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25

A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24

Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24